17p缺失慢性淋巴细胞白血病患者的依鲁替尼皮疹 - Suppr

Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.

作者信息

Mannis Gabriel, Wu Davina, Dea Tiffany, Mauro Theodora, Hsu Gerald

机构信息

Department of Medicine, Division of Hematology/Oncology, San Francisco Veterans Affairs Medical Center, San Francisco, California.

出版信息

Am J Hematol. 2015 Feb;90(2):179. doi: 10.1002/ajh.23775. Epub 2014 Jun 20.

DOI:10.1002/ajh.23775

PMID:24890909

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4548957/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffc/4548957/3d8ad6294476/nihms-716105-f0001.jpg

相似文献

Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.17p缺失慢性淋巴细胞白血病患者的依鲁替尼皮疹

Am J Hematol. 2015 Feb;90(2):179. doi: 10.1002/ajh.23775. Epub 2014 Jun 20.

Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.评估 3 项临床试验中 230 例复发/难治性 17p 缺失慢性淋巴细胞白血病患者接受伊布替尼治疗的情况。

Br J Haematol. 2018 Aug;182(4):504-512. doi: 10.1111/bjh.15421. Epub 2018 Jun 5.

Ibrutinib-Induced Neutrophilic Dermatosis.依鲁替尼诱发的嗜中性皮病。

Am J Dermatopathol. 2018 Mar;40(3):198-200. doi: 10.1097/DAD.0000000000000862.

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.评估伊布替尼治疗伴有 del(11q)的慢性淋巴细胞白血病患者的长期结局的研究。

Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):715-722.e6. doi: 10.1016/j.clml.2019.07.004. Epub 2019 Jul 15.

Dose-limiting stomatitis associated with ibrutinib therapy: a case series.与依鲁替尼治疗相关的剂量限制性口腔炎：病例系列

Br J Haematol. 2019 May;185(4):784-788. doi: 10.1111/bjh.15620. Epub 2018 Nov 8.

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.一线伊布替尼治疗老年慢性淋巴细胞白血病患者的持续疗效和详细临床随访：RESONATE-2 扩展阶段 3 的结果。

Haematologica. 2018 Sep;103(9):1502-1510. doi: 10.3324/haematol.2018.192328. Epub 2018 Jun 7.

Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report.接受依鲁替尼治疗的慢性淋巴细胞白血病患者发生膀胱软斑病：一例报告

Anticancer Res. 2016 Sep;36(9):4759-62. doi: 10.21873/anticanres.11032.

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p.伊布替尼作为无 17p 缺失的老年慢性淋巴细胞白血病一线治疗的成本效益。

Blood Adv. 2018 Aug 14;2(15):1946-1956. doi: 10.1182/bloodadvances.2017015461.

Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.1例接受伊布替尼治疗B细胞慢性淋巴细胞白血病的患者白内障摘除术后前房纤维蛋白样综合征：病例报告及文献复习

J Med Case Rep. 2018 Nov 16;12(1):349. doi: 10.1186/s13256-018-1822-9.

What should standard frontline therapy be in older patients with chronic lymphocytic leukemia? Ibrutinib should be standard frontline therapy.老年慢性淋巴细胞白血病患者的标准一线治疗应该是什么？依鲁替尼应作为标准一线治疗。

Clin Adv Hematol Oncol. 2016 May;14(5):330-3.

引用本文的文献

Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia.一名慢性淋巴细胞白血病患者的依鲁替尼相关白细胞破碎性血管炎

Turk J Haematol. 2024 Mar 1;41(1):57-58. doi: 10.4274/tjh.galenos.2023.2023.0368.

Wells' syndrome possibly caused by hematologic malignancy, influenza vaccination or ibrutinib: A case report.可能由血液系统恶性肿瘤、流感疫苗接种或依鲁替尼引起的威尔斯综合征：一例报告。

World J Clin Cases. 2022 Oct 26;10(30):10997-11003. doi: 10.12998/wjcc.v10.i30.10997.

Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study.慢性淋巴细胞白血病患者完全或部分缓解后依鲁替尼减量给药的疗效：一项初步研究。

J Hematol. 2020 Sep;9(3):55-61. doi: 10.14740/jh676. Epub 2020 Aug 14.

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.在自身免疫性疾病模型中 BTK 抑制剂 Evobrutinib 的疗效和药效动力学建模。

J Immunol. 2019 May 15;202(10):2888-2906. doi: 10.4049/jimmunol.1800583. Epub 2019 Apr 15.

Ibrutinib-associated pityriasis rosea-like rash.依鲁替尼相关的玫瑰糠疹样皮疹。

JAAD Case Rep. 2017 Dec 19;4(1):55-57. doi: 10.1016/j.jdcr.2017.06.035. eCollection 2018 Jan.

Ibrutinib-Associated Nail Plate Abnormalities: Case Reports and Review.依鲁替尼相关的甲板异常：病例报告与综述

Drug Saf Case Rep. 2017 Nov 1;4(1):15. doi: 10.1007/s40800-017-0060-1.

Ibrutinib-Associated Skin Toxicity: A Case of Maculopapular Rash in a 79-Year Old Caucasian Male Patient with Relapsed Waldenstrom's Macroglobulinemia and Review of the Literature.依鲁替尼相关的皮肤毒性：一例79岁复发性华氏巨球蛋白血症白种男性患者的斑丘疹病例及文献综述

Dermatol Reports. 2017 Apr 20;9(1):6976. doi: 10.4081/dr.2017.6976. eCollection 2017 Mar 13.

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.伊布替尼长期治疗慢性淋巴细胞白血病期间的毛发和指甲变化

JAMA Dermatol. 2016 Jun 1;152(6):698-701. doi: 10.1001/jamadermatol.2016.0225.

本文引用的文献

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial.伊布替尼作为初治老年慢性淋巴细胞白血病或小淋巴细胞淋巴瘤患者的治疗方案：一项开放标签、多中心、1b/2 期临床试验。

Lancet Oncol. 2014 Jan;15(1):48-58. doi: 10.1016/S1470-2045(13)70513-8. Epub 2013 Dec 10.

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.伊布替尼治疗复发慢性淋巴细胞白血病的 BTK 靶点。

N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.伊布替尼治疗复发或难治性套细胞淋巴瘤中的 BTK。

N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献